Neuroblastoma — Trials

Neuroblastoma — Trials · CancerIndex

Clinical trials

Registered studies

616 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 51–59 of 59 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00670410	Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma	terminated	Phase 1	15	Columbia UniversityOTHER	1	Jun 24, 2016	clinicaltrials
NCT01440283	A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma	terminated	Phase 2	14	St. Jude Children's Research HospitalOTHER	1	Mar 3, 2016	clinicaltrials